Patents by Inventor Sylvain Contie

Sylvain Contie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sequences, antibodies, methods and kits for detection and in vitro assay of periostin, in order to provide a diagnosis, follow-up or prognosis of diseases and biological phenomena involving periostin
    Patent number: 9115190
    Abstract: Detection sequences of periostin having from 6 to 30 amino acids and which include all or part of peptide sequence SEQ ID No. 1, SEQ ID No. 2 or SEQ ID No. 3, or a homologous peptide sequence. Antibodies suitable for specifically recognizing minimally one of these detection sequences, including an anti-periostin antibody, are disclosed. Periostin detection and dosage processes and kits that use these antibodies are also disclosed. A periostin marker for early diagnosis, tracking and prognosis of pathologies that involve periostin, including benign osteolysis such as inflammatory diseases, including osteoarticular diseases, and malignant osteolysis, such as cancers with bone metastases, is provided.
    Type: Grant
    Filed: June 3, 2010
    Date of Patent: August 25, 2015
    Assignees: SYNARC SAS, INSERM
    Inventors: Patrick Garnero, Sylvain Contie, Nathalie Rousselot, Philippe Clezardin
  • SEQUENCES, ANTIBODIES, METHODS AND KITS FOR DETECTION AND IN VITRO ASSAY OF PERIOSTIN, IN ORDER TO PROVIDE A DIAGNOSIS, FOLLOW-UP OR PROGNOSIS OF DISEASES AND BIOLOGICAL PHENOMENA INVOLVING PERIOSTIN
    Publication number: 20120219977
    Abstract: Detection sequences of periostin having from 6 to 30 amino acids and which include all or part of peptide sequence SEQ ID No. 1, SEQ ID No. 2 or SEQ ID No. 3, or a homologous peptide sequence. Antibodies suitable for specifically recognizing minimally one of these detection sequences, including an anti-periostin antibody, are disclosed. Periostin detection and dosage processes and kits that use these antibodies are also disclosed. A periostin marker for early diagnosis, tracking and prognosis of pathologies that involve periostin, including benign osteolysis such as inflammatory diseases, including osteoarticular diseases, and malignant osteolysis, such as cancers with bone metastases, is provided.
    Type: Application
    Filed: June 3, 2010
    Publication date: August 30, 2012
    Inventors: Patrick Garnero, Sylvain Contie, Nathalic Rousselot, Philippe Clezardin